Why is Shree Ganesh Bio falling/rising?

As of 24-Sep, Shree Ganesh Biotech India Ltd is currently priced at Rs 0.77, showing no change (0.00%). The stock has underperformed in the short term, with a 1-week return of -2.53%, and it is trading lower than its moving averages across all time frames. Additionally, it is close to its 52-week low, just 3.9% away from Rs 0.74. The company has been experiencing operating losses, reflected in its weak long-term fundamental strength, and it has a poor EBIT to Interest ratio of 0.97. Furthermore, the stock's return on equity is low at 2.52%, indicating low profitability. The recent delivery volume has also decreased by 18.25% compared to the 5-day average, suggesting falling investor participation.
In the broader market context, the Sensex has shown a slight gain of 0.50% over the past month, contrasting with Shree Ganesh Biotech's 1-month decline of -2.53%. The agriculture sector, in which the company operates, has fallen by 3.88%, contributing to the stock's struggles. Over the past year, while the stock has returned -28.70%, its profits have decreased by 48%, further emphasizing the company's financial difficulties. Overall, the combination of weak performance metrics, declining investor interest, and sector challenges has led to a negative outlook for Shree Ganesh Biotech.